Showing results (301-310 of 422) with videos related to

Sort By:
Pageof 43
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
ERJ Open Research|January 16, 2024
Outcomes and risk assessment in pulmonary veno-occlusive diseaseAthénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
Respiratory Medicine|August 31, 2010
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthmaPascal Chanez, Cécile Contin-Bordes, Gilles Garcia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With PolyangiitisParameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 13, 2025
Asthma in the Biologics Era: Should Oral Corticosteroid Therapy Be Relegated to History?Florence Schleich, John J Oppenheimer, Guy Brusselle, et al.
The New England Journal of Medicine|February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
ESC Heart Failure|June 8, 2021
Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS studyDany Jaffuel, Erika Nogue, Philippe Berdague, et al.
The European Respiratory Journal|December 23, 2018
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult casesMélanie Eyries, David Montani, Sophie Nadaud, et al.
Pageof 43